Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.7)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2014, vol. 23, nr 4, July-August, p. 511–516

Publication type: original article

Language: English

Chlamydia Trachomatis Promotes 3T3 Cell Differentiation into Adipocytes

Ivan M. Petyaev1,A,C,D,F, Nailya A. Zigangirova2,B,E,G, Lydia N. Kapotina2,B,C, Elena D. Fedina2,B,C, Nigel H. Kyle1,B,E,G

1 Lycotec Ltd, Granta Park Campus, Cambridge, United Kingdom

2 Institute of Epidemiology and Microbiology, Ministry of Health, Moscow, Russia

Abstract

Background. There is experimental and clinical evidence showing that some viral and bacterial pathogens are linked to the accumulation of excessive body fat and obesity.
Objectives. The aim of the study was to investigate the ability of C. trachomatis to propagate in the pre-adipocyte cell line and induce its differentiation into fat cells.
Material and Methods. 3T3 L1 pre-adipocytes or McCoy cells were plated and infected with C. trachomatis. The cell monolayers were further studied by immunofluorescent and quantitative RT-PCR methods.
Results. C. trachomatis can efficiently propagate in 3T3 L1 cells, a mouse pre-adipocyte cell line. The morphological characteristics of chlamydial growth revealed in 3T3 L1 cells with the monoclonal chlamydial MOMP-specific antibody resembled those seen in McCoy cells, a classic cell line used for chlamydial research. The number of chlamydial 16S rRNA copies detectable in the lysates of McCoy and 3T3 cells infected with C. trachomatis was almost identical, suggesting similar efficiency of pathogen propagation in both cell lines. Moreover, there was a significant increase in aP2 mRNA transcript levels as well as moderate induction of SCD-1 mRNA in the total RNA extracted from the infected 3T3 L1 cells 48 h following the pathogen inoculation. The increased expression of the adipogenic markers was also accompanied by lipid droplet accumulation in the C. trachomatis infected 3T3 L1 cells, suggesting their transformation into differentiated adipocytes.
Conclusion. The direct effect of the pathogen on fat cell progenitors observed in this work may explain abnormal fat deposition at the sites of chronic inflammation caused by C. trachomatis .

Key words

C. trachomatis, adipocytes, differentiation.

References (21)

  1. Lin WY, Dubuisson O, Rubicz R, Liu N, Allison DB, Curran JE, Comuzzie AG, Blangero J, Leach CT, Göring H, Dhurandhar NV: Long-Term Changes in Adiposity and Glycemic Control Are Associated With Past Adenovirus Infection. Diabetes Care 2013, 36, 701–707.
  2. Wang ZQ, Cefalu WT, Zhang XH, Yu Y, Qin J, Son L, Rogers PM, Mashtalir N, Bordelon JR, Ye J, Dhurandhar NV: Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes 2008, 57, 1805–1813.
  3. Wang ZQ, Yu Y, Zhang XH, Qin J, Floyd E: Gene expression profile in human skeletal muscle cells infected with human adenovirus type 36. J Med Virol 2012, 84, 1254–1266.
  4. Mitra AK, Clarke K: Viral obesity: fact or fiction? Obes Rev 2010, 11, 289–296.
  5. Pasarica M, Dhurandhar NV: Infectobesity: Obesity of infectious origin. Adv Food Nutr Res 2007, 52, 61–102.
  6. Fei N, Zhao L: An opportunistic pathogen isolated from the gut of an obese human causes obesity in germ free mice. ISME J 2013, 7, 880–884.
  7. Galescu O, Bhangoo A, Ten S: Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS. Rev Endocr Metab Disord 2013, 14, 133–140.
  8. Suplicy H.L, Bornschein A: Infections as the etiology for obesity. Arq Bras Endocrinol Metabol 2009, 53, 159–164.
  9. Galdwell HD, Kromhout J, Schachter J: Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981, 31, 1161–1176.
  10. Brunham RC, Rappuoli R: Chlamydia trachomatis control requires a vaccine. Vaccine 2013, 8, 31, 1892–1897.
  11. Manavi K: A review on infection with Chlamydia trachomatis. Best Pract Res Clin Obstet Gynaecol 2006, 20, 941–951.
  12. Jamil MS1, Bauer HM, Hocking JS, Ali H, Wand H, Walker J, Douglas L, Donovan B, Kaldor JM, Guy RJ: Chlamydia screening strategies and outcomes in educational settings: a systematic review. Sex Transm Dis 2014, 41, 180–187.
  13. Shi Y, Liu Y, Murdin A, Raudonikiene-Mancevski A, Ayach BB, Yu Z, Fantus IG, Liu PP: Chlamydophila pneumoniae inhibits differentiation of progenitor adipose cells and impairs insulin signaling. J Infect Dis 2008, 1, 197, 439–448.
  14. Elwell CA, Engel JN: Lipid acquisition by intracellular Chlamydiae. Cell Microbiol 2012, 14, 1010–1018.
  15. Kumar Y, Cocchiaro J, Valdivia RH: The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol 2006, 22, 16, 1646–1651.
  16. Subtil A: Rerouting of host lipids by bacteria: are you CERTain you need a vesicle? PLoS Pathog 2011, 7, e1002208.
  17. Sales KJ, Katz AA: Inflammatory pathways in cervical cancer – the UCT contribution. S Afr Med J 2012, 23, 102, 493–496.
  18. Tsinzerling AV: Chlamydiosis: diagnosis and role in human pathology. Arkh Patol 1989, 51, 3–9.
  19. Jung SI, Kim YJ, Park HS, Jeon HJ, Jeong KA: Acute pelvic inflammatory disease: diagnostic performance of CT. J Obstet Gynaecol Res 2011, 37, 228–235.
  20. Mesurolle B, Mignon F, Gagnon JH: Fitz-Hugh-Curtis syndrome caused by Chlamydia trachomatis: atypical CT findings. AJR Am J Roentgenol 2004, 182, 822–824.
  21. Shimada N, Honda Y, Sugimoto M: Image diagnosis of abdominal infectious diseases (infectious enterocolitis and Fitz-Hugh-Curtis Syndrome). Nihon Rinsho 2007, 28, 65, Suppl 2, 1, 247–250.
© Wroclaw Medical University